SOMATULINE AUTOGEL SOLUTION (EXTENDED RELEASE) Канада - англійська - Health Canada

somatuline autogel solution (extended release)

ipsen biopharmaceuticals canada inc - lanreotide (lanreotide acetate) - solution (extended release) - 120mg - lanreotide (lanreotide acetate) 120mg - other miscellaneous therapeutic agents

SOMATULINE P.R. 30 MG Ізраїль - англійська - Ministry of Health

somatuline p.r. 30 mg

medison pharma ltd - lanreotide acetate - powder and solvent for suspension for injection - lanreotide acetate 0.03 g/vial - lanreotide - lanreotide - treatment of acromegaly (when the treatment of growth hormone is not normalized after surgery and/or radiotherapy). treatment of the clinical symptoms of carcinoid tumors (after a test injection). treatment of primary thyrotropic adenomas responsible for hypethyroidism as a preparation for / or as a complement to surgery and/or radiotherapy or where these therapies are unsuitable.

Somatuline Autogel Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

somatuline autogel

new zealand medical & scientific ltd - lanreotide 24.6%{relative} (as 50.7 %w/w lanreotide acetate) - solution for injection - 24.6 mg/ml - active: lanreotide 24.6%{relative} (as 50.7 %w/w lanreotide acetate) excipient: glacial acetic acid water for injection - latest regulatory activity

Somatuline LA Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

somatuline la

new zealand medical & scientific ltd - lanreotide acetate 30mg (includes 10mg overage);   - powder for injection - 30 mg - active: lanreotide acetate 30mg (includes 10mg overage)   excipient: carmellose sodium mannitol polyglactin   polysorbate 80 mannitol water for injection